These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. [Clinical observations on the hemostatic activity of the sulfonic ester of adrenochrome semicarbazone]. De Biasi R; Berardi G Riforma Med; 1965 Jul; 79(30):822-4. PubMed ID: 5319507 [No Abstract] [Full Text] [Related]
4. Clinical use of hemostatic agents. Lowe GD; Lawson DH J Maine Med Assoc; 1978 Mar; 69(3):87-97. PubMed ID: 650082 [No Abstract] [Full Text] [Related]
5. [141 MD (Dicynone) in ORL. New synthetic hemostatic and antihemorrhagic agent]. Wayoff M; Jeannin A; Jeannin C Ann Otolaryngol Chir Cervicofac; 1966; 83(4):361-70. PubMed ID: 5935945 [No Abstract] [Full Text] [Related]
6. [Testing of a new synthetic hemostatic and antihemorrhagic agent in surgical practice]. Loygue J; Lévy E Mem Acad Chir (Paris); 1965 Mar; 91(10):331-8. PubMed ID: 5317949 [No Abstract] [Full Text] [Related]
7. [Drugs for control of hemodynamic disorders]. Merlen JF; Hiltenbrand C Angeiologie; 1967; 20():Suppl:61-3. PubMed ID: 5621509 [No Abstract] [Full Text] [Related]
8. [Bleeding time and hemostatic agents]. Roskam J Rev Med Liege; 1973 Aug; 28(16):565-8. PubMed ID: 4755005 [No Abstract] [Full Text] [Related]
9. [Hemostatics and anticoagulants]. Haddad R Rev Dent Liban; 1973 Dec; 23(4):31-51. PubMed ID: 4544160 [No Abstract] [Full Text] [Related]
10. [On the treatment of vascular fragility appearing during prolonged anticoagulation]. Cloetens W; Colin W; Michel J Angeiologie; 1967; 19(5):53-66. PubMed ID: 5621974 [No Abstract] [Full Text] [Related]
11. [Control and regulation of fibrinolysis in patients with arteriopathies by the use of an extractive mucopolysaccharide complex]. Centonza D; Brina A; De Cristoforo A Minerva Med; 1969 Dec; 60(99 Suppl):5023-33. PubMed ID: 4188586 [No Abstract] [Full Text] [Related]
12. [Correction of hypocoagulemia in the preoperative period]. Darbunian TM; Titova MI; Rostisheva SS; Andreev SD Sov Med; 1975 Nov; (11):8-12. PubMed ID: 1221534 [No Abstract] [Full Text] [Related]
13. Management of the dental patient on anticoagulant medication. Rada RE Dent Today; 2006 Aug; 25(8):58-63. PubMed ID: 16925162 [No Abstract] [Full Text] [Related]
14. Supplementation of fibrinogen in acquired bleeding disorders: experience, evidence, guidelines, and licences. Ranucci M; Solomon C Br J Anaesth; 2012 Aug; 109(2):135-7. PubMed ID: 22782975 [No Abstract] [Full Text] [Related]
15. [Experience in the use of pyrogenal in the treatment of vascular diseases of the lower extremities]. Kargin VD; Klimova KN; Damsker IS Sov Med; 1968 Apr; 31(4):19-23. PubMed ID: 5669768 [No Abstract] [Full Text] [Related]
17. [Effect of some haemostatic preparations on rats subjected to whole-body irradiation (author's transl)]. Pospísil J; Skala E; Poucková P; Dienstbier Z Sb Lek; 1982 Apr; 84(4):122-7. PubMed ID: 7100811 [No Abstract] [Full Text] [Related]
18. Hemostatic effects of microfibrillar collagen hemostat (MCH) in experimental coagulopathy model and its mechanism of hemostasis. Hatsuoka M; Seiki M; Sasaki K; Kashii A Thromb Res; 1986 May; 42(3):407-12. PubMed ID: 3520941 [No Abstract] [Full Text] [Related]
19. [Effect of an arterial wall extract in various retinal vascular diseases]. Bracciolini MR; Ranieri G Ann Ottalmol Clin Ocul; 1968 Jun; 94(6):705-13. PubMed ID: 5758584 [No Abstract] [Full Text] [Related]